FCPA Blog – Revisiting EpiPen: Steep incentive thresholds are corporate disasters waiting to happen

February 13, 2017

Marc Hodak, partner at Farient Advisors, explains how steep incentive thresholds were behind the Epipen scandal and how companies can learn from Mylan’s mistake.

Read More

© 2022 Farient Advisors LLC. | Privacy Policy | Site by: Treacle Media